Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 08-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14 | 2 | 3 | 6 | N/A |
| Other current assets | 0 | 0 | 286 | 0 | 44 |
| TOTAL | $14 | $2 | $345 | $17 | $44 |
| Non-Current Assets | |||||
| PPE Net | N/A | 7 | 13 | 18 | N/A |
| Intangibles | 14 | 14 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 198 |
| TOTAL | $14 | $21 | $13 | $18 | $198 |
| Total Assets | $28 | $23 | $358 | $35 | $241 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13 | 83 | 146 | 118 | 0 |
| Accrued Expenses | N/A | 43 | 26 | 26 | N/A |
| TOTAL | $13 | $341 | $558 | $242 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 308 | 120 | 3 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 628 | 587 | 0 |
| TOTAL | $N/A | $308 | $748 | $590 | $N/A |
| Total Liabilities | $13 | $648 | $1,306 | $832 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,206 | 41,466 | 27,710 | 8,444 | N/A |
| Common Shares | 22 | 18 | 269 | 69 | N/A |
| Retained earnings | -22,223 | -19,453 | -18,419 | -17,531 | N/A |
| Other shareholders' equity | 0 | -2,529 | -1,127 | -249 | 1 |
| TOTAL | $15 | $-626 | $-948 | $-797 | $1 |
| Total Liabilities And Equity | $28 | $23 | $358 | $35 | $1 |